Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 5
2020 5
2021 3
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Menez S, Wen Y, Xu L, Moledina DG, Thiessen-Philbrook H, Hu D, Obeid W, Bhatraju PK, Ikizler TA, Siew ED, Chinchilli VM, Garg AX, Go AS, Liu KD, Kaufman JS, Kimmel PL, Himmelfarb J, Coca SG, Cantley LG, Parikh CR. Menez S, et al. Kidney Int. 2023 Dec;104(6):1194-1205. doi: 10.1016/j.kint.2023.08.007. Epub 2023 Aug 29. Kidney Int. 2023. PMID: 37652206 Free article.
Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing Outcomes.
Vasquez-Rios G, Oh W, Lee S, Bhatraju P, Mansour SG, Moledina DG, Gulamali FF, Siew ED, Garg AX, Sarder P, Chinchilli VM, Kaufman JS, Hsu CY, Liu KD, Kimmel PL, Go AS, Wurfel MM, Himmelfarb J, Parikh CR, Coca SG, Nadkarni GN. Vasquez-Rios G, et al. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):716-726. doi: 10.2215/CJN.0000000000000156. Epub 2023 Mar 28. Clin J Am Soc Nephrol. 2023. PMID: 36975209
Longitudinal biomarkers and kidney disease progression after acute kidney injury.
Wen Y, Xu L, Melchinger I, Thiessen-Philbrook H, Moledina DG, Coca SG, Hsu CY, Go AS, Liu KD, Siew ED, Ikizler TA, Chinchilli VM, Kaufman JS, Kimmel PL, Himmelfarb J, Cantley LG, Parikh CR; ASSESS-AKI Consortium. Wen Y, et al. JCI Insight. 2023 May 8;8(9):e167731. doi: 10.1172/jci.insight.167731. JCI Insight. 2023. PMID: 36951957 Free PMC article.
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Coca SG, Vasquez-Rios G, Mansour SG, Moledina DG, Thiessen-Philbrook H, Wurfel MM, Bhatraju P, Himmelfarb J, Siew E, Garg AX, Hsu CY, Liu KD, Kimmel PL, Chinchilli VM, Kaufman JS, Wilson M, Banks RE, Packington R, McCole E, Kurth MJ, Richardson C, Go AS, Selby NM, Parikh CR. Coca SG, et al. Am J Kidney Dis. 2023 Feb;81(2):190-200. doi: 10.1053/j.ajkd.2022.08.007. Epub 2022 Sep 13. Am J Kidney Dis. 2023. PMID: 36108888 Free PMC article.
Biomarkers of inflammation and repair in kidney disease progression.
Puthumana J, Thiessen-Philbrook H, Xu L, Coca SG, Garg AX, Himmelfarb J, Bhatraju PK, Ikizler TA, Siew ED, Ware LB, Liu KD, Go AS, Kaufman JS, Kimmel PL, Chinchilli VM, Cantley LG, Parikh CR. Puthumana J, et al. J Clin Invest. 2021 Feb 1;131(3):e139927. doi: 10.1172/JCI139927. J Clin Invest. 2021. PMID: 33290282 Free PMC article.
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.
Brar S, Liu KD, Go AS, Hsu RK, Chinchilli VM, Coca SG, Garg AX, Himmelfarb J, Ikizler TA, Kaufman J, Kimmel PL, Parikh CR, Siew ED, Ware LB, Zeng H, Hsu CY; ASsessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) study investigators; ASSESS-AKI Investigators. Brar S, et al. Clin J Am Soc Nephrol. 2020 Dec 31;16(1):26-36. doi: 10.2215/CJN.10840720. Epub 2020 Dec 3. Clin J Am Soc Nephrol. 2020. PMID: 33272913 Free PMC article.
20 results